Study blood and tissue markers in pancreatic cancer
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at “biomarkers” (test signals in tissue or blood) in people with pancreatic cancer. It may help researchers understand the disease better and find ways to predict or track it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have pancreatic cancer that has been confirmed by pathology (microscope test)
- Your diagnosis is either pancreatic duct cancer or ampullary cancer, if it was resected (removed) or otherwise confirmed based on clinical and scan findings
- Be able to provide the resected tissue specimen if you had surgery, or the appropriate pathology confirmation if you did not
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This study looks at how certain substances in your blood and bacteria in your gut might help predict pancreatic cancer, especially in people with chronic pancreatitis. It aims to find early warning signs to catch cancer sooner.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This study analyzes immune system markers in blood samples to help predict which people with chronic pancreatitis (long-term pancreas inflammation) might develop pancreatic cancer. Researchers will compare blood patterns in healthy people, those with chronic pancreatitis, and those recently diagnosed with pancreatic cancer.
This trial uses a blood test (called cfDNA) to look for early signs of pancreatic cancer. It compares results from people with pancreatic cancer, precancerous changes, non-cancerous pancreatic conditions, and healthy individuals to improve early detection.
This study collects samples of substances in your blood to learn more about pancreatic cancer. It may help researchers find better ways to track the disease or understand which patients may benefit from future treatments.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.